Review of SARS-CoV-2 and Conjunctivitis: Ophthalmologists Be Safe
Published: October 1, 2020 | DOI: https://doi.org/10.7860/JCDR/2020/44972.14116
Mona P Sune, Pradeep Sune, Vishal Kalode
1. Associate Professor, Department of Ophthalmology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Deemed University), Sawangi, Wardha, Maharashtra, India.
2. Professor, Department of Ophthalmology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Deemed University), Sawangi, Wardha, Maharashtra, India.
3. Assistant Professor, Department of Ophthalmology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Deemed University), Sawangi, Wardha, Maharashtra, India.
Correspondence
Mona P Sune,
Himalaya Vishwa Colony, Plot No. M-4, Wardha-442001, Maharashtra, India.
E-mail: drmonasune@gmail.com
The COVID-19 or the Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) has become pandemic with its origin in Wuhan, city of China. Within few weeks, it became a global health threat involving more than 200 countries. Though the main route of transmission is by respiratory droplets; trans-conjunctival aerosol infection is a known mode of disease transmission. Patients with COVID-19 conjunctivitis have the transmissible virus in the tears. Close contact during ophthalmic procedures poses the risk of patient to ophthalmologist disease transmission. Conjunctivitis may be the first symptom of COVID-19. In context to this and the close proximity of an ophthalmologist and Health Care Workers (HCW) with the patient, and the nature of work, standard infection protection measures guidelines have been given by prominent healthcare societies.
[
FULL TEXT ] | [ PDF]